Literature DB >> 3768766

Edrophonium and plasma cholinesterase activity.

R K Mirakhur.   

Abstract

Plasma cholinesterase activity was estimated following administration of edrophonium 0.5 or 1.0 mg X kg-1 given for antagonism of atracurium-induced neuromuscular block. There was no inhibition of enzyme activity for up to three hours following edrophonium administration. This is in contrast to profound and prolonged inhibition of enzyme activity seen following neostigmine and pyridostigmine.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3768766     DOI: 10.1007/bf03014265

Source DB:  PubMed          Journal:  Can Anaesth Soc J        ISSN: 0008-2856


  16 in total

1.  Prolonged apnoea after suxamethonium in man.

Authors:  D E ARGENT; O P DINNICK; F HOBBIGER
Journal:  Br J Anaesth       Date:  1955-01       Impact factor: 9.166

2.  Evaluation of curarizing drugs in man. V. Antagonism to curarizing effects of d-tubocurarine by neostigmine, m-hydroxy phenyltrimethylammonium and m-hydroxy phenylethyldimethylammonium.

Authors:  D W MacFARLANE; E W PELIKAN; K R UNNA
Journal:  J Pharmacol Exp Ther       Date:  1950-11       Impact factor: 4.030

3.  Effects of neostigmine and pyridostigmine on duration of succinylcholine action and pseudocholinesterase activity.

Authors:  K Y Sunew; R G Hicks
Journal:  Anesthesiology       Date:  1978-09       Impact factor: 7.892

4.  Effects of neostigmine and pyridostigmine on serum cholinesterase activity.

Authors:  R K Mirakhur; T D Lavery; L P Briggs; R S Clarke
Journal:  Can Anaesth Soc J       Date:  1982-01

Review 5.  Antagonism of neuromuscular blockade.

Authors:  R Cronnelly; R B Morris
Journal:  Br J Anaesth       Date:  1982-02       Impact factor: 9.166

6.  The inhibition of cholinesterases by pancuronium.

Authors:  J Stovner; N Oftedal; J Holmboe
Journal:  Br J Anaesth       Date:  1975-09       Impact factor: 9.166

7.  Reversal of pancuronium with edrophonium.

Authors:  D R Bevan
Journal:  Anaesthesia       Date:  1979 Jul-Aug       Impact factor: 6.955

8.  Antagonism of the muscarinic effects of edrophonium with atropine or glycopyrrolate. A comparative study.

Authors:  R K Mirakhur
Journal:  Br J Anaesth       Date:  1985-12       Impact factor: 9.166

9.  Protein binding of atracurium and other short-acting neuromuscular blocking agents and their interaction with human cholinesterases.

Authors:  F F Foldes; A Deery
Journal:  Br J Anaesth       Date:  1983       Impact factor: 9.166

10.  Edrophonium: duration of action and atropine requirement in humans during halothane anesthesia.

Authors:  R Cronnelly; R B Morris; R D Miller
Journal:  Anesthesiology       Date:  1982-10       Impact factor: 7.892

View more
  4 in total

1.  Chemical weapons.

Authors:  L Karalliedde; C A Gauci; M Carter
Journal:  BMJ       Date:  1991-02-23

Review 2.  Neuromuscular transmission and its pharmacological blockade. Part 3: Continuous infusion of relaxants and reversal and monitoring of relaxation.

Authors:  L H Booij
Journal:  Pharm World Sci       Date:  1997-02

3.  The reversal of profound mivacurium-induced neuromuscular blockade.

Authors:  Y J Kao; N D Le
Journal:  Can J Anaesth       Date:  1996-11       Impact factor: 5.063

4.  Neostigmine but not edrophonium prolongs the action of mivacurium.

Authors:  M J Symington; R K Mirakhur; N Kumar
Journal:  Can J Anaesth       Date:  1996-12       Impact factor: 5.063

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.